Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.037 | 0.7 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |